Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies

References

Page 1

	Year	Citations
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics Yoshinobu Kanda Bone Marrow Transplantation	2012	17.9K
Hematological Problems in Pediatric Intensive Care Shoshana Revel‐Vilk, Peter N. Cox, Nancy Robitaille, Pediatric and adolescent medicine	2013	3.5K
Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation Fletcher B. Taylor, Cheng‐Hock Toh, Keith Hoots, Thrombosis and Haemostasis Laboratory CriteriaEducationThrombosisVenous ThrombosisStroke	2001	2.2K
Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial Hiroaki Saito, Ikuro Maruyama, S Shimazaki, Journal of Thrombosis and Haemostasis ThrombosisCardiovascular DiseaseMedicinePhase IiiHematology	2006	594
Criteria for Diagnosis of DIC Based on the Analysis of Clinical and Laboratory Findings in 345 DIC Patients Collected by the Research Committee on DIC in Japan Norio Kobayashi, Tadashi Maekawa, M Takada, Current studies in hematology and blood transfusion DiagnosisPathologyMedical DiagnosisThrombosisHematology	2015	312
Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation FB Jr Taylor Thrombosis and Haemostasis ThrombosisCardiovascular DiseaseMedicineScientific SubcommitteeHematology	2001	175
Inhibitory Effect of a New Synthetic Protease Inhibitor (FUT-175) on the Coagulation System Yuji Hitomi, Nobuhiko Ikari, Setsuro Fujii Pathophysiology of Haemostasis and Thrombosis	1985	137
Pharmacological Studies of FUT-175, Nafamostat Mesilate V. Effects on the Pancreatic Enzymes and Experimental Acute Pancreatitis in Rats Masahiro Iwaki, Y. Ino, Akemi Motoyoshi, The Japanese Journal of Pharmacology InflammationGastrointestinal Peptide HormonePancreatic CancerPharmacological StudiesGastrointestinal Pharmacology	1986	121
FOY: [Ethylp-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitro Hiroyuki Ohno, G Kōsaki, Junichi Kambayashi, Thrombosis Research Inhibitory ActivitySerine Proteinase InhibitorMedicinal ChemistryBiochemistryMedicine	1980	57
Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro. Yoshitaka Ino, Kunihiko Suzuki, Takuo Sato, Folia Pharmacologica Japonica	1986	14

Page 1